Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Craig R Lewis"'
Autor:
Stephen Morrell, David Roder, David Currow, Alexander Engel, Elizabeth Hovey, Craig R. Lewis, Winston Liauw, Jarad M. Martin, Manish Patel, Stephen R. Thompson, Tracey O’Brien
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionPopulation cancer registries record primary cancer incidence, mortality and survival for whole populations, but not more timely outcomes such as cancer recurrence, secondary cancers or other complications that disrupt event-free survival.
Externí odkaz:
https://doaj.org/article/d1d3e0de469048abb7922cdee13e1781
Autor:
Kosar Hooshmand, David Goldstein, Hannah C. Timmins, Tiffany Li, Michelle Harrison, Michael L. Friedlander, Craig R. Lewis, Justin G. Lees, Gila Moalem-Taylor, Boris Guennewig, Susanna B. Park, John B. Kwok
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background Genetic risk factors for chemotherapy-induced peripheral neuropathy (CIPN), a major dose-limiting side-effect of paclitaxel, are not well understood. Methods We performed a genome-wide association study (GWAS) in 183 paclitaxel-tr
Externí odkaz:
https://doaj.org/article/2c68d9d7c95a4ee5840e68ef1badc7f5
Autor:
Jeremy Chung Bo Chiang, David Goldstein, Azadeh Tavakoli, Terry Trinh, Jacob Klisser, Craig R. Lewis, Michael Friedlander, Thomas J. Naduvilath, Kimberley Au, Susanna B. Park, Arun V. Krishnan, Maria Markoulli
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Immune cell infiltration has been implicated in neurotoxic chemotherapy for cancer treatment. However, our understanding of immune processes is still incomplete and current methods of observing immune cells are time consuming or invasive. Co
Externí odkaz:
https://doaj.org/article/00382dae9ddf41f08fab328294b408ea
Autor:
Rachel Woodford, Deborah Zhou, Sarah J Lord, Ian Marschner, Wendy A Cooper, Craig R Lewis, Thomas John, James Chih-Hsin Yang, Chee Khoon Lee
Publikováno v:
Future Oncology. 18:1793-1799
Background: In metastatic non-small-cell lung cancer (mNSCLC), PD-L1 expression is associated with benefit from immune checkpoint inhibitor (ICI) therapy. However, the significance of PD-L1 expression in chemotherapy-treated patients is uncertain. Me
Autor:
Terry Trinh, Thomas Naduvilath, Craig R. Lewis, Kimberley Au, Jeremy Chung Bo Chiang, Jacob Klisser, Michael Friedlander, Maria Markoulli, Azadeh Tavakoli, Susanna B. Park, Arun V. Krishnan, David Goldstein
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Scientific Reports
Scientific Reports
Immune cell infiltration has been implicated in neurotoxic chemotherapy for cancer treatment. However, our understanding of immune processes is still incomplete and current methods of observing immune cells are time consuming or invasive. Corneal den
Autor:
Steven Kao, Tessa A. Morris, Mark Voskoboynik, Benjamin Solomon, Luke McLean, Wasek Faisal, Ross Jennens, Sagun Parakh, Craig R. Lewis, Malinda Itchins, Adam R. Broad, Melvin Chin
Publikováno v:
JCO Precision Oncology. :561-568
PURPOSE Leptomeningeal disease (LMD) in epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma is associated with a poor prognosis and limited treatment options. Osimertinib is a potent third-generation EGFR tyrosine kinase inhibitor with
Autor:
Monica Tang, Thomas John, R. J. Simes, Sallie-Anne Pearson, Craig R. Lewis, Chee Khoon Lee, Andrea L Schaffer
Publikováno v:
Journal of Geriatric Oncology. 12:930-936
Objectives Older adults constitute the majority of patients with lung cancer. However, they are under-represented in clinical trials as eligibility criteria often restrict enrolment based on comorbidities that are common with aging. We aimed to descr
Autor:
Benjamin Solomon, Tristan Shaffer, Po Yee Yip, S. Liang, Nick Pavlakis, Mark Li, Tristan A. Barnes, Malinda Itchins, Adnan Nagrial, G. Peters, Stephen Clarke, S. Kao, Christopher L. Brown, Venessa T. Chin, Craig R. Lewis, Bob T. Li, Gavin Marx, Victoria J Bray
Publikováno v:
Journal of Thoracic Oncology. 16:S1030-S1032
Autor:
Jeremy Shapiro, Brian Stein, Phillipa Smith, Christos S. Karapetis, Craig R. Lewis, Liesel Byrne, Lisa King, Aisling Kelly, Wanyuan Cui, Julia Shingleton, Rachel Wong
Publikováno v:
Internal Medicine Journal. 50:1338-1343
BACKGROUND: Evidence supporting dose modifications to reduce serious treatment-related adverse events of antineoplastic therapy is limited and frequently based on clinical trial protocols, which are not always generalisable to community patients. evi
Autor:
Christa E. Nath, Samiuela Lee, Toby Trahair, Peter J. Shaw, Ben W.R. Balzer, Antoinette Anazodo, Craig R. Lewis
Publikováno v:
Acta Chromatographica. 32:166-169
Alectinib is a central nervous system-active small molecule anaplastic lymphoma kinase (ALK) inhibitor that is effective in the treatment of patients with ALK positive tumors, including advanced non-small cell lung cancers and lymphomas. A simple, is